Compare MARA & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MARA | IRTC |
|---|---|---|
| Founded | 2010 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.9B |
| IPO Year | 2010 | 2016 |
| Metric | MARA | IRTC |
|---|---|---|
| Price | $13.80 | $116.62 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 13 |
| Target Price | $17.85 | ★ $197.92 |
| AVG Volume (30 Days) | ★ 38.4M | 509.7K |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 61.71 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $907,093,000.00 | $747,138,000.00 |
| Revenue This Year | N/A | $19.60 |
| Revenue Next Year | $13.31 | $15.94 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 38.20 | 26.24 |
| 52 Week Low | $6.66 | $108.81 |
| 52 Week High | $23.45 | $210.01 |
| Indicator | MARA | IRTC |
|---|---|---|
| Relative Strength Index (RSI) | 65.17 | 47.20 |
| Support Level | $9.65 | $112.65 |
| Resistance Level | $16.63 | $127.50 |
| Average True Range (ATR) | 0.90 | 6.01 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 87.64 | 39.43 |
MARA Holdings Inc leverages digital asset computing to support the energy transformation. It secures the blockchain ledger and supports the energy transformation by converting clean, stranded, or underutilized energy into economic value. The company also offers technology solutions to optimize data center operations, including next-generation liquid immersion cooling and firmware for Bitcoin miners. It is focused on computing for, acquiring, and holding digital assets as a long-term investment.
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.